Consultation on proposed changes to the classification of vitamin D pursuant to the Medicines Regulations 1984

1. What is your name?

2. What is your email address?

3. Are you providing feedback:

(Required) As an individual On behalf of an organisation or group

If responding on behalf of an organisation or group, please provide the name of the organisation or group:

4. Where are you or your organisation/group based?

New Zealand Other

If you selected 'Other', please specify:

5. Which of the below best describes you in the context of this consultation?

(Required) Pharmaceutical industry Healthcare professional Regulatory consultant Government Researcher and/or academic institution Professional body Consumer organisation Member of the public Other

If you selected 'Other', please specify:

Your Details